Meet the experts driving innovation at eXmoor Pharma. Our leadership, scientific, and business teams bring decades of combined experience in process development, GMP manufacturing, facility design, and consulting, working together to accelerate advanced therapies from concept to commercialisation.
About Us
Our Team

Meet Our Team


Angela Osborne
Founder and CEO


Ian Rhodes
Interim Chairman


Lucy Foley
Chief Technology Officer

Graham Henderson
Chief Financial Officer and Board Observer


Gavin Sutton
Executive Director Capital Projects


Gillian Lewis
Chief Consultant

Emma Ewins
Head of GMP


Charlotte Nodwell
Head of HR


David Vincent
Head of Process Development


Termeh Ahmadraji
Head of Operations


Remy Martin
Commercial Manager


Carol Elvira
Business Development Manager


Ruxandra Comisel
Consultant Analyst


Helen Jones
Marketing Manager

Shailesh Maingi
Board Observer, Kineticos Ventures

Tom Casdagli
Board Member, MVM Partners

Frank Lis
Board Member, Kineticos Ventures

Jack Tanaka
Board Member, MVM Partners

James Miskin
Non-Executive Director

Kate Fynes
Senior CMC Translation Consultant


Ryan Guest
Senior CMC Translation Consultant


Clare Blue
Senior CMC Translation Consultant


Harvey Branton
Senior Translation Consultant


Chrissy Claudius
Project Manager


Robert Scott
Head of Translation Consultancy


Drew Hope
Senior Bio Manufacturing & Compliance Consultant & EU QP


Evelien Stalmeijer
Chief Cell & Gene Therapy Consultant


Vittoria Ardissone
GMP Compliance Consultant and QP


John Joseph
Bioprocessing Engineering Consultant


Paul Dempsey
Architect


Andrew Besso
Senior Bioprocess Consultant


Daphné Bocciarelli
Head of Vector


Adam Janvier
Head of Cell Therapy


Corinne McEwan
Head of RNA
Let’s Accelerate Your Therapy Together
Whether you’re in early-stage development or scaling up for commercial production, eXmoor Pharma provides the expertise and flexibility you need. Partner with us to move your therapy forward with confidence.
Latest News

Scaling Gene Therapy Production: From Bench to Clinic

eXmoor Pharma and KU Leuven announce strategic partnership to accelerate cell and gene therapy innovation through new venture
